Articles by Jill Wechsler - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Jill Wechsler

Health-Reform Controversies

Courts and Congress seek to reshape policies and programs.
Apr 2, 2011

Courts and Congress seek to reshape policies and programs.

Drug Safety and Shortages Challenge Manufacturers

As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.
Mar 2, 2011

As drug shortages make headlines, FDA tests the Sentinel safety system and its efect on healthcare.

FDA Faces Internal Changes and Challenges

Food-safety, transparency, and counterfeit-drug growth will tax agency resources.
Feb 2, 2011

Food-safety, transparency, and counterfeit-drug growth will tax agency resources.

Cost and Compliance Dominate Agenda for 2011

Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.
Jan 2, 2011

Top priorities for manufacturers include user fees, new health initiatives, and regulatory compliance.

Pharma Faces New Political Landscape

Republican gains in Congress create uncertainty for healthcare reform, drug regulation, and biomedical research.
Dec 2, 2010

Republican gains in Congress create uncertainty for healthcare reform, drug regulation, and biomedical research.

Comparative Research Poses Challenges

A new center may provide evidence for improving care, but could discourage coverage of treatments.
Nov 2, 2010

A new center may provide evidence for improving care, but could discourage coverage of treatments.

Administration Seeks to Modernize Vaccine Production

President Obama and HHS eye innovation and countermeasures to protect public health.
Oct 2, 2010

President Obama and HHS eye innovation and countermeasures to protect public health.

FDA Struggles with Risk Management and Drug Safety

Weighing the pros and cons of REMS for bringing risky products to market.
Sep 2, 2010

Weighing the pros and cons of REMS for bringing risky products to market.

Manufacturing Failures Place GMP Compliance in Spotlight

Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.
Aug 2, 2010

Fallout escalates from McNeil recall and Genzyme shortages as regulators review oversight.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here